Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy

BACKGROUND: Pregnancy Associated Osteoporosis (PAO) can lead to serious difficulties such as fragility fractures, elongated back pain and height loss in affected women. Soluble Receptor Activator of Nuclear Factor-Kappa B ligand (sRANKL) to Osteoprotegerin (OPG) ratio is chosen as a bone metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: FATHI MAROUFI, Nazila, GHORBANIHAGHJO, Amir, SAYYAH MELLI, Manizheh, VAEZI, Maryam, HEKMATI AZAR MEHRABANI, Zohreh, BANNAZADEH AMIRKHIZ, Maryam, RASHTCHIZADEH, Nadereh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439041/
https://www.ncbi.nlm.nih.gov/pubmed/28540268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439041/
https://www.ncbi.nlm.nih.gov/pubmed/28540268

Ejemplares similares